

|

|

Volume 5:
No. 3, July 2008
ORIGINAL RESEARCH
National Trends and Disparities in the Incidence of Hepatocellular
Carcinoma, 1998–2003
Men, by Race
Age, y |
Rate per 100,000 |
All races |
White |
Black |
Asian/Pacific Islander |
20-24 |
0.1 |
0.1 |
0.2 |
0.4 |
25-29 |
0.2 |
0.1 |
0.4 |
1.1 |
30-34 |
0.3 |
0.2 |
0.7 |
2.1 |
35-39 |
0.8 |
0.4 |
1.5 |
5.3 |
40-44 |
2.3 |
1.8 |
3.8 |
8.5 |
45-49 |
7.5 |
6.1 |
14.0 |
18.9 |
50-54 |
11.0 |
8.9 |
23.0 |
27.1 |
55-59 |
12.3 |
10.0 |
23.5 |
37.2 |
60-64 |
15.1 |
12.5 |
22.6 |
56.0 |
65-69 |
20.6 |
18.0 |
26.1 |
71.1 |
70-74 |
24.1 |
21.6 |
31.8 |
75.2 |
75-79 |
27.0 |
25.2 |
27.6 |
80.0 |
80-84 |
23.2 |
21.7 |
24.7 |
70.6 |
≥85 |
17.9 |
16.6 |
19.7 |
57.9 |
Women, by Race
Age, y |
Rate per 100,000 |
All races |
White |
Black |
Asian/Pacific Islander |
20-24 |
0.1 |
0.1 |
0.1 |
0.4 |
25-29 |
0.1 |
0.1 |
0.1 |
0.1 |
30-34 |
0.1 |
0.1 |
0.2 |
0.5 |
35-39 |
0.2 |
0.2 |
0.5 |
0.6 |
40-44 |
0.5 |
0.3 |
1.0 |
1.6 |
45-49 |
1.2 |
1.0 |
2.0 |
2.4 |
50-54 |
1.7 |
1.4 |
2.9 |
4.6 |
55-59 |
2.6 |
2.1 |
4.4 |
7.3 |
60-64 |
4.2 |
3.4 |
5.9 |
18.2 |
65-69 |
6.5 |
5.2 |
8.2 |
30.1 |
70-74 |
8.1 |
7.0 |
10.9 |
33.2 |
75-79 |
8.8 |
7.8 |
11.6 |
30.7 |
80-84 |
8.6 |
7.8 |
10.3 |
34.5 |
≥85 |
6.1 |
5.9 |
5.5 |
19.8 |
Men and Women, by Ethnicity
Age, y |
Rate per 100,000 |
Hispanic men |
Non-Hispanic men |
Hispanic women |
Non-Hispanic women |
20-24 |
0.1 |
0.1 |
0 |
0.1 |
25-29 |
0.1 |
0.2 |
0.1 |
0.1 |
30-34 |
0.3 |
0.4 |
0.1 |
0.2 |
35-39 |
0.7 |
0.8 |
0.2 |
0.2 |
40-44 |
3.5 |
2.2 |
0.4 |
0.5 |
45-49 |
13.8 |
6.8 |
1.7 |
1.1 |
50-54 |
19.6 |
10.2 |
2.7 |
1.7 |
55-59 |
27.1 |
11.1 |
5.9 |
2.3 |
60-64 |
31.5 |
13.9 |
9.7 |
3.8 |
65-69 |
46.3 |
18.7 |
15.8 |
5.8 |
70-74 |
49.6 |
22.5 |
19.8 |
7.4 |
75-79 |
60.6 |
25.2 |
26.6 |
7.8 |
80-84 |
44.7 |
22.3 |
24.0 |
8.0 |
≥85 |
40.7 |
16.8 |
22.5 |
5.5 |
Figure 1. Age-Specific Incidence of Hepatocellular
Carcinoma, by Patients’ Sex and Race/Ethnicity, United States, 1998–2003.
Data cover 83% of the U.S. population and are from population-based cancer registries that participate in the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program and that met study criteria.
Return to article
Characteristic |
APC |
Male |
Female |
Race/Ethnicity |
White |
4.8a |
4.5a |
Black |
6.0a |
1.7 |
Asian/Pacific Islander |
0.4 |
1.2 |
Hispanic |
3.6a |
1.8 |
Age, y |
<45 |
-0.6 |
-1.6 |
45-59 |
9.0a |
9.0a |
60-74 |
3.6a |
3.2a |
≥75 |
2.6a |
3.8a |
Region |
Midwest |
3.6a |
2.9 |
South |
5.9a |
5.2a |
Northeast |
6.2a |
5.9a |
West |
3.3a |
3.0 |
Race/Ethnicity (Among Those Aged
45-59 y) |
White |
10.4a |
9.5a |
Black |
8.9a |
12.3a |
Asian/Pacific Islander |
-2.7 |
-0.3 |
Hispanic |
8.8a |
3.5 |
Figure 2. Annual Percentage Change (APC) in Incidence
of Hepatocellular Carcinoma, United States, 1998–2003.
Data cover 83% of the U.S. population and are from population-based cancer registries that participate in the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program and that met study criteria.
a P < .05 indicates that the APC is significantly greater than zero.
Return to article
|
|